Indiana Polyclinic has officially announced the availability of a stem cell treatment for sufferers of rheumatoid arthritis, providing a means to stop inflammation and pain.
Indianapolis, Indiana, April 20, 2018 – Indiana Polyclinic, a leading multidisciplinary facility in Indianapolis, Indiana, has today announced the rollout of a new stem cell treatment option designed to benefit sufferers of rheumatoid arthritis (RA).
Rheumatoid arthritis is an autoimmune disease in which the body’s own immune system attacks its tissues, predominantly within the joints in the hands and feet, but also within other joints in the body. RA can also affect internal organs. There is no cure, and many treatment options are stopgap at best. However, stem cell therapy promises long-term relief and even reversal of the damage.